Insider Trading Alert - WDR, ACAS, EEFT, CVD And ACGL Traded By Insiders

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

Friday, Nov. 22, 2013, 166 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $98.40 to $54,600,947.10.

Highlighted Stocks Traded by Insiders:

Waddell & Reed Financial (WDR) - FREE Research Report

Logue Dennis E who is Director at Waddell & Reed Financial sold 7,000 shares at $64.74 on Nov. 22, 2013. Following this transaction, the Director owned 49,361 shares meaning that the stake was reduced by 12.42% with the 7,000 share transaction.

The shares most recently traded at $63.98, down $0.76, or 1.18% since the insider transaction. Historical insider transactions for Waddell & Reed Financial go as follows:

  • 4-Week # shares sold: 13,000
  • 12-Week # shares sold: 13,000
  • 24-Week # shares bought: 61
  • 24-Week # shares sold: 49,540

The average volume for Waddell & Reed Financial has been 648,900 shares per day over the past 30 days. Waddell & Reed Financial has a market cap of $5.6 billion and is part of the financial sector and financial services industry. Shares are up 83.72% year to date as of the close of trading on Friday.

Waddell & Reed Financial, Inc., through its subsidiaries, provides investment management, investment product underwriting and distribution, and shareholder services administration to mutual funds, and institutional and separately managed accounts in the United States. The stock currently has a dividend yield of 1.71%. The company has a P/E ratio of 24.7. Currently there are 2 analysts that rate Waddell & Reed Financial a buy, 1 analyst rates it a sell, and 6 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on WDR - FREE

TheStreet Quant Ratings rates Waddell & Reed Financial as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, good cash flow from operations, compelling growth in net income, notable return on equity and solid stock price performance. Although no company is perfect, currently we do not see any significant weaknesses which are likely to detract from the generally positive outlook. Get the full Waddell & Reed Financial Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

American Capital (ACAS) - FREE Research Report

Winn Darin who is Senior Vice President at American Capital sold 7,843 shares at $15.00 on Nov. 22, 2013. Following this transaction, the Senior Vice President owned 340,114 shares meaning that the stake was reduced by 2.25% with the 7,843 share transaction.

The shares most recently traded at $15.10, up $0.10, or 0.66% since the insider transaction. Historical insider transactions for American Capital go as follows:

  • 4-Week # shares sold: 54,990
  • 12-Week # shares bought: 15,000
  • 12-Week # shares sold: 72,600
  • 24-Week # shares bought: 15,000
  • 24-Week # shares sold: 91,111

The average volume for American Capital has been 2.1 million shares per day over the past 30 days. American Capital has a market cap of $4.2 billion and is part of the financial sector and financial services industry. Shares are up 24.29% year to date as of the close of trading on Friday.

American Capital, Ltd. is a private equity and venture capital firm specializing in management and employee buyouts, leveraged finance, mezzanine, acquisition, recapitalization, middle market, and growth capital investments. The company has a P/E ratio of 23.3. Currently there are 3 analysts that rate American Capital a buy, 1 analyst rates it a sell, and 4 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on ACAS - FREE

TheStreet Quant Ratings rates American Capital as a hold. The company's strengths can be seen in multiple areas, such as its good cash flow from operations, increase in stock price during the past year and notable return on equity. However, as a counter to these strengths, we find that the growth in the company's earnings per share has not been good. Get the full American Capital Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

Euronet Worldwide (EEFT) - FREE Research Report

Weller Rick who is Chief Financial Officer/ EVP at Euronet Worldwide sold 25,000 shares at $47.26 on Nov. 22, 2013. Following this transaction, the Chief Financial Officer/ EVP owned 69,822 shares meaning that the stake was reduced by 26.37% with the 25,000 share transaction.

The shares most recently traded at $48.38, up $1.12, or 2.32% since the insider transaction. Historical insider transactions for Euronet Worldwide go as follows:

  • 4-Week # shares sold: 141,415
  • 12-Week # shares sold: 141,415
  • 24-Week # shares sold: 269,783

The average volume for Euronet Worldwide has been 231,700 shares per day over the past 30 days. Euronet Worldwide has a market cap of $2.4 billion and is part of the services sector and diversified services industry. Shares are up 99.83% year to date as of the close of trading on Friday.

Euronet Worldwide, Inc. provides payment and transaction processing and distribution solutions to financial institutions, retailers, service providers, and individual consumers. The company operates in three segments: EFT Processing, epay, and Money Transfer. The company has a P/E ratio of 37.4. Currently there are 3 analysts that rate Euronet Worldwide a buy, no analysts rate it a sell, and 1 rates it a hold.

Exclusive Offer: Get the latest Stock Analysis on EEFT - FREE

TheStreet Quant Ratings rates Euronet Worldwide as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, good cash flow from operations, compelling growth in net income, notable return on equity and solid stock price performance. We feel these strengths outweigh the fact that the company shows low profit margins. Get the full Euronet Worldwide Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

Covance (CVD) - FREE Research Report

Nutt Brian H. who is Principal Accounting Officer at Covance sold 165 shares at $65.67 on Nov. 22, 2013. Following this transaction, the Principal Accounting Officer owned 1,099 shares meaning that the stake was reduced by 13.05% with the 165 share transaction.

The shares most recently traded at $84.10, up $18.43, or 21.91% since the insider transaction. Historical insider transactions for Covance go as follows:

  • 12-Week # shares sold: 11,200
  • 24-Week # shares bought: 200
  • 24-Week # shares sold: 112,400

The average volume for Covance has been 306,100 shares per day over the past 30 days. Covance has a market cap of $4.8 billion and is part of the health care sector and health services industry. Shares are up 45.14% year to date as of the close of trading on Friday.

Covance Inc., a drug development services company, provides various early-stage and late-stage product development services primarily to the pharmaceutical, biotechnology, and medical device industries primarily in the United States and Europe. The company has a P/E ratio of 28.6. Currently there are 7 analysts that rate Covance a buy, 1 analyst rates it a sell, and 7 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on CVD - FREE

TheStreet Quant Ratings rates Covance as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, solid stock price performance, reasonable valuation levels and good cash flow from operations. We feel these strengths outweigh the fact that the company shows low profit margins. Get the full Covance Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

Arch Capital Group (ACGL) - FREE Research Report

Meenaghan James J who is Director at Arch Capital Group sold 2,000 shares at $58.09 on Nov. 22, 2013. Following this transaction, the Director owned 46,059 shares meaning that the stake was reduced by 4.16% with the 2,000 share transaction.

The shares most recently traded at $59.23, up $1.14, or 1.92% since the insider transaction. Historical insider transactions for Arch Capital Group go as follows:

  • 4-Week # shares sold: 41,000
  • 12-Week # shares sold: 51,000
  • 24-Week # shares sold: 51,000

The average volume for Arch Capital Group has been 338,700 shares per day over the past 30 days. Arch Capital Group has a market cap of $7.8 billion and is part of the financial sector and insurance industry. Shares are up 32.26% year to date as of the close of trading on Friday.

Arch Capital Group Ltd., through its subsidiaries, provides insurance and reinsurance solutions worldwide. It operates in two segments, Insurance and Reinsurance. The company has a P/E ratio of 14.5. Currently there are 2 analysts that rate Arch Capital Group a buy, 1 analyst rates it a sell, and 11 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on ACGL - FREE

TheStreet Quant Ratings rates Arch Capital Group as a buy. The company's strengths can be seen in multiple areas, such as its solid stock price performance, largely solid financial position with reasonable debt levels by most measures, notable return on equity and good cash flow from operations. We feel these strengths outweigh the fact that the company shows low profit margins. Get the full Arch Capital Group Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

Data for this article provided by Zacks Investment Research

null

More from Markets

Dow Sinks for Eighth Straight Session; Intel's CEO Departs -- ICYMI

Dow Sinks for Eighth Straight Session; Intel's CEO Departs -- ICYMI

Dow Logs Eighth Straight Drop as Stocks Slump

Dow Logs Eighth Straight Drop as Stocks Slump

This Is What's Hot Thursday - Stocks Slide, Intel's CEO Woes & Major Movers

This Is What's Hot Thursday - Stocks Slide, Intel's CEO Woes & Major Movers

U.S. Banks Pass Fed 'Stress Test' With Room for Dividends, Buybacks

U.S. Banks Pass Fed 'Stress Test' With Room for Dividends, Buybacks

U.S. Drillers at Mercy of Iran, Saudi Production Spat as OPEC Meeting Begins

U.S. Drillers at Mercy of Iran, Saudi Production Spat as OPEC Meeting Begins